Description

Deslanoside is a potent cardiac glycoside derived from lanatoside C, primarily used as a reference standard and active pharmaceutical ingredient in cardiovascular research and development. Its high purity and well-defined structure make it a critical component for ensuring the accuracy and reliability of analytical methods and pharmacological studies. This compound is essential for pharmaceutical manufacturers, research institutions, and quality control laboratories focused on cardiac therapeutics and analytical chemistry.

Application

• Pharmaceutical Reference Standard: Used as a primary standard for the identification, assay, and impurity profiling of related cardiac glycosides in pharmacopeial testing (e.g., USP, EP).
• Cardiovascular Research: Serves as a key biochemical tool in preclinical studies investigating inotropic agents, sodium-potassium ATPase inhibition, and heart failure mechanisms.
• Active Pharmaceutical Ingredient (API) Intermediate: Employed in the synthesis and quality control of finished dosage forms for cardiac medications.
• Analytical Method Development: Critical for developing and validating HPLC, LC-MS, and other chromatographic methods for cardiac drug analysis.
• Biochemical Assays: Used in enzyme inhibition studies and receptor binding assays to study cardiac cell function.
• Quality Control & Compliance Testing: Ensures batch-to-batch consistency and regulatory compliance for manufacturers of digoxin and related cardiac drugs.

Basic Information

Product Name	Deslanoside
CAS No.	17598-65-1
Molecular Formula	C47H74O19
Molecular Weight	943.08 g/mol
Synonyms	Desacetyl-lanatoside C; Deacetyllanatoside C; Deslanoside; Lanatoside D; Desacetyllanatoside C; NSC 107679; Desacetyldigilanide C; (3β,5β,12β)-3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
EINECS	Contact for details

Quality Control

Our Deslanoside is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including identification (IR, HPLC), assay (HPLC), and impurity profiling to ensure it meets high-purity standards suitable for pharmaceutical research and development. Certificates of Analysis (COA) detailing all test results are provided and can be tailored to meet specific pharmacopeial requirements (USP, EP, BP).

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference standard
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥98.0%
Water Content (KF)	≤2.0%
Residue on Ignition	≤0.1%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.